CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 24 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Ketamine 5mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01507181
NCT01507181Phase 4Completed
CompareCT.gov

Investigating Rapid Anti-Suicidal Ideation Effects of Intravenous (IV) Ketamine in Hospitalized Patients

James Murrough·interventional·Posted Jan 10, 2012·Updated Feb 8, 2017

In Brief

A Phase 4 clinical trial evaluating Ketamine and Midazolam for Suicidal Ideation. Completed, enrolled 24 participants across 1 site.

Detailed Summary

This study will examine the effects of Intravenous (IV) ketamine both in an outpatient population and with subjects on the inpatient unit with suicidal ideation (SI).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSuicidal Ideation
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 10, 2012
Enrollment StartJan 1, 2012
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 14.5 years ago

Interventions

Ketaminedrug

single dose IV ketamine, .5mg/kg infused over 40 minutes

Midazolamdrug

single dose IV midazolam, .45mg/kg infused over 40 minutes